RETROSPHER. ERBB2 amplification detection in the plasma at diagnosis for early high-risk HER2-positive breast cancer von Sabatier, R., Garnier, S., Carbuccia, N., Guille, A., Tarpin, C., Goncalves, A., Birnbaum, D.

Volltext

Characteristics, treatment patterns and survival of patients with high-risk early hormone receptor-positive breast cancer in French real-world settings: an exploratory study of the... von Giugliano, F., Bertaut, A., Blanc, J., Martin, A.-L., Gaudin, C., Fournier, M., Kieffer, A., Sauterey, B., Levy, C., Campone, M., Tarpin, C., Lerebours, F., Mouret-Reynier, M.-A., Curigliano, G., André, F., Pistilli, B., Rassy, E.

Volltext

Effects of termite sheetings on soil properties under two contrasting soil management practices von Lejoly, J., Cornelis, J.-T., Van Ranst, E., Jansegers, E., Tarpin, C., Degré, A., Colinet, G., Malaisse, F.

Volltext

Investigating sexual health after breast cancer by longitudinal assessment of patient-reported outcomes von Franzoi, M.A., Aupomerol, M., Havas, J., Soldato, D., Lambertini, M., Massarotti, C., Hang, H., Pistilli, B., Fasse, L., Tredan, O., Gillanders, E., Joly, F., Cottu, P., Mouret-Reynier, M.-A., Tarpin, C., Arnaud, A., Everhard, S., Martin, A.-L., Di Meglio, A., Vaz-Luis, I.

Volltext

Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation von Boudin, L, Gonçalves, A, Sabatier, R, Moretta, J, Sfumato, P, Asseeva, P, Livon, D, Bertucci, F, Extra, J-M, Tarpin, C, Houvenaegel, G, Lambaudie, E, Tallet, A, Resbeut, M, Sobol, H, Charafe-Jauffret, E, Calmels, B, Lemarie, C, Boher, J-M, Viens, P, Eisinger, F, Chabannon, C

Volltext

Factors associated with enrolment in clinical trials among women with early-stage breast cancer von Presti, D., Havas, J., Soldato, D., Lapidari, P., Martin, E., Pistilli, B., Jouannaud, C., Emile, G., Rigal, O., Fournier, M., Soulie, P., Mouret-Reynier, M.-A., Tarpin, C., Campone, M., Guillermet, S., Martin, A.-L., Everhard, S., Di Meglio, A.

Volltext

Buccodental side effects of sunitinib in patients with metastatic renal cell carcinoma von Gilabert, M, Provansal, M, Cappiello, M, Walz, Y, Salem, N, Tarpin, C, Brunelle, S, Thomassin, J, Gravis, G

Volltext

Analyse rétrospective monocentrique des résultats de la chirurgie pour compression médullaire métastatique : taux de survie, facteurs pronostiques et efficacité clinique von Fuentes, S, Tabouret, E, Cauvin, C, Esterni, B, Adetchessi, T, Madroszyk, A, Gonçalves, A, Casalonga, F, Brunelle, S, Salem, N, Gonzague, L, Tarpin, C, Gravis, G

Volltext

Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation von Boudin, L, Gonçalves, A, Sabatier, R, Moretta, J, Sfumato, P, Asseeva, P, Livon, D, Bertucci, F, Extra, J-M, Tarpin, C, Houvenaeghel, G, Lambaudie, E, Tallet, A, Resbeut, M, Sobol, H, Charafe-Jauffret, E, Calmels, B, Lemarie, C, Boher, J-M, Viens, P, Eisinger, F, Chabannon, C

Volltext

Immunohistochemical subtypes predict the clinical outcome in high-risk node-negative breast cancer patients treated with adjuvant FEC regimen: results of a single-center retrospect... von Rahal, S, Boher, J M, Extra, J M, Tarpin, C, Charafe-Jauffret, E, Lambaudie, E, Sabatier, R, Thomassin-Piana, J, Tallet, A, Resbeut, M, Houvenaeghel, G, Laborde, L, Bertucci, F, Viens, P, Gonçalves, A

Volltext

Participants’ uptake of clinical trial results: a randomised experiment von Mancini, J, Genre, D, Dalenc, F, Ferrero, J-M, Kerbrat, P, Martin, A-L, Roché, H, Maylevin, F, Tarpin, C, Viens, P, Genève, J, Julian-Reynier, C

Volltext

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial von Kerbrat, Pierre, Fumoleau, Pierre, Jacquin, Jean-Philippe, Abadie-Lacourtoisie, Sophie, Cany, Laurent, Khayat, David, Paget-Bailly, Sophie, Demarchi, F, N'Guyen, T, Stein, U, Villanueva, C, Guimont, I, Lévy, E, Delbaldo, C, Pouessel, D, Fournel-Fédérico, C, Freyer, G, Tartas, S, Bons, F, Cuvier, C, Hajjaji, N, Capitain, O, Maillart, P, Bonnefoi, H, Durand, M, Madranges, N, Mauriac, L, Durando, X, Durieux, A, Piperno-Neumann, S, Tresca, P, Ferrant, E, Mayer, F, Vanneuville, AC, Servent, V, Guastalla, JP, Biron, P, Dupuy-Brousseau, L, Lancry, L, Trédan, O, Extra, JM, Berton-Rigaud, D, Ferrero, JM, Largillier, R, Gedoin, D, Laguerre, B, Lefeuvre, C, Vauléon, E, Tennevet, I, Mefti-Lacheraf, F, Dalenc, F, André, F, Domont, J, Ezenfis, J, Provençal, J, Bellaiche-Miccio, C, Boutan-Laroze, G, Arsène, O, Merad-Boudia, Z, Orfeuvre, H, Lamy, R, Sarda, C, Salles, B, Cauvin, I, Mangold, M, Bourcier, A, Geay, JF, ElAmarti, R, Combe, M, Dauba, J, Denizon, N, Clavreul, G, Goubely, Y, Delecroix, V, Ligeza-Poisson, V, Leyronnas, C, Teissier, E, Bernard, O, Pottier-Kyndt, V, Drony, S, Moriceau, M, Besson, D, Achille, E, Moran-Ribon, A, Moullet, I, Couderc, B, Burki, F, Schaeffer, F, Montcuquet, P, Baumont, GA, Gréget, S, Ratoanina, JL, Bonichon-Lamichhane, M, Cartron, G, Dupuis, O, Ganem, G, LeRol, A, Antoine, EC, Llory, JF, Loiseau, D

Volltext

6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial von Pivot, Xavier, Prof, Romieu, Gilles, MD, Debled, Marc, MD, Pierga, Jean-Yves, Prof, Kerbrat, Pierre, Prof, Bachelot, Thomas, MD, Lortholary, Alain, MD, Espié, Marc, MD, Fumoleau, Pierre, Prof, Serin, Daniel, MD, Jacquin, Jean-Philippe, MD, Jouannaud, Christelle, MD, Rios, Maria, MD, Abadie-Lacourtoisie, Sophie, MD, Tubiana-Mathieu, Nicole, Prof, Cany, Laurent, MD, Catala, Stéphanie, MD, Khayat, David, Prof, Pauporté, Iris, PhD, Kramar, Andrew, PhD

Volltext

Quality of life in a heterogeneous sample of caregivers of cancer patients: an in-depth interview study von MANCINI, J., BAUMSTARCK-BARRAU, K., SIMEONI, M.-C., GROB, J.-J., MICHEL, G., TARPIN, C., LOUNDOU, A.-D., LAMBERT, A., CLÉMENT, A., AUQUIER, P.

Volltext

2PRETROSPHER. ERBB2 amplification detection in the plasma at diagnosis for early high-risk HER2-positive breast cancer von Sabatier, R, Garnier, S, Carbuccia, N, Guille, A, Tarpin, C, Goncalves, A, Birnbaum, D

Volltext

166P Metabolomic prediction of breast cancer treatment toxicities von Piffoux, M., Jacquemin, J., Petera, M., Boyault, S., Martin, A-L., Everhard, S., André, F., Pistilli, B., Fournier, M., Rouanet, P., Dhaini Merimeche, A., Sauterey, B., Campone, M., Tarpin, C., Mouret Reynier, M.A., Rigal, O., Petit, T., Pujos Guillot, E., Drouet, Y., Tredan, O.

Volltext

1558MO Dissecting sexual health after breast cancer (BC) by longitudinal assessment of patient reported outcomes von Franzoi, M.A., Aupomerol, M., Havas, J., Hang, H., Di Meglio, A., Lambertini, M., Massarotti, C., Coutant, C., Tredan, O., Joly Lobbedez, F., Cottu, P.H., Soldato, D., Mouret, M-A., Tarpin, C., Arnaud, A., Fasse, L., Everhard, S., Martin, A-L., Pistilli, B., Luis, I.V.

Volltext

Gene expression profiling identifies molecular subtypes of inflammatory breast cancer von BERTUCCI, Francois, FINETTI, Pascal, VIENS, Patrice, BIRNBAUM, Daniel, ROUGEMONT, Jacques, CHARAFE-JAUFFRET, Emmanuelle, CERVERA, Nathalie, TARPIN, Carole, NGUYEN, Catherine, XERRI, Luc, HOULGAWE, Rémi, JACQUEMIER, Jocelyne

Volltext

High-dose Alkylating Agents with Autologous Hematopoietic Stem Cell Support and Trastuzumab in ERBB2 Overexpressing Metastatic Breast Cancer: A Feasibility Study von GONCALVES, A, BRAUD, A. C, VIRET, F, TARPIN, C, CHARAFFE-JAUFFRET, E, JACQUEMIER, J, MARANINCHI, D, VIENS, P

Volltext

134P Enrolment in clinical trials (CT) among patients (pts) with early breast cancer (BC) von Presti, D., Havas, J., Soldato, D., Lapidari, P., Martin, E., Pistilli, B., Martin, A-L., Everhard, S., Jouannaud, C., Levy, C., Rigal, O., Fournier, M., Soulié, P., Mouret-Reynier, M-A., Tarpin, C., Campone, M., Guillermet, S., André, F., Vaz-Luis, I., Di Meglio, A.

Volltext